NCT05388890View on ClinicalTrials.gov

Treatment of Atrophic Gastritis After HP Eradication With Modified Liujunzi Decoction Based on Syndrome Differentiation

RecruitingOBSERVATIONAL
Enrollment

286

Participants

Timeline

Start Date

August 2, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Chronic Atrophic Gastritis
Interventions
DRUG

MLD

Modified Liujunzi Decoction is provided by the chinese pharmacy of Peking University First Hospital , one dose per day, taken in twice, and the course of treatment is 6 months.

DRUG

WFC

Chinese patent medicine, take according to the instructions, the course of treatment is 6 months.

Trial Locations (1)

100034

RECRUITING

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER